Merck Drug Boosts Survival From Hard-to-Treat Uterine Cancer
Merck Drug Boosts Survival From Hard-to-Treat Uterine Cancer Yahoo Finance UK
Онкология
🎗️Лента новостей
Онкология
Triplet Therapy With Abiraterone Improves OS Long-Term in Metastatic Castration-Sensitive Prostate Cancer
Triplet Therapy With Abiraterone Improves OS Long-Term in Metastatic Castration-Sensitive Prostate Cancer The ASCO Post
Онкология
Next-Gen Drug Significantly Prevents Return of and Death From Endometrial Cancer
Next-Gen Drug Significantly Prevents Return of and Death From Endometrial Cancer NYU Langone Health
Онкология
После лечения рака: бывшая невестка Дональда Трампа рассказала о своем здоровье
После лечения рака: бывшая невестка Дональда Трампа рассказала о своем здоровье ТСН
Онкология
Implantable device uses ultrasound to improve drug delivery to the brain
Patients with glioblastoma, an aggressive type of brain tumor, usually undergo surgery to remove the tumor. However, it's difficult for surgeons to remove all of the cancer cells, and the tumor often recurs.
Онкология
BioVana, NICRAT Partner to Establish National Cancer Biobank Network |
BioVana, NICRAT Partner to Establish National Cancer Biobank Network | Business Post Nigeria
Онкология
Technology Takes Aim at Psychological Distress in Patients with Cancer
Technology Takes Aim at Psychological Distress in Patients with Cancer Cleveland Clinic
Онкология
Perioperative apalutamide in high-risk localized or locally advanced prostate cancer substudy supports reduced risk of metastasis and death | Newswise
Perioperative apalutamide in high-risk localized or locally advanced prostate cancer substudy supports reduced risk of metastasis and death | Newswise Newswise
Онкология
В США начали испытывать японский метод лечения рака красным светом
В США начали испытывать японский метод лечения рака красным светом Incrussia
Онкология
Next-generation drug reduces endometrial cancer progression and death in trial
A new drug is effective at decreasing the recurrence of, and death from, endometrial cancer, an international study shows. The drug, called sacituzumab tirumotecan (sac-TMT), attaches to a protein on the surface of tumor cells and then delivers a targeted dose of a chemical that leads to cancer cell death.
Онкология
На снимке почти ничего не видно: ИИ научился находить ранние признаки рака поджелудочной железы
На снимке почти ничего не видно: ИИ научился находить ранние признаки рака поджелудочной железы Правда.Ру
Онкология
Phase II HRS-4642 Plus Chemotherapy With or Without Adebrelimab in KRAS G12D-Mutant Pancreatic Cancer: Preliminary Results at ESMO 2026
Phase II HRS-4642 Plus Chemotherapy With or Without Adebrelimab in KRAS G12D-Mutant Pancreatic Cancer: Preliminary Results at ESMO 2026 Oncodaily
🎗️
Онкология
Не только про женщин: что нужно знать каждому о профилактике рака молочной железы
Не только про женщин: что нужно знать каждому о профилактике рака молочной железы Твериград